Trials / Unknown
UnknownNCT05312762
To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds
An Open Label, Multicentre, Randomized Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MaxioCel Compared With Aquacel Extra for the Management of Exuding Chronic Wounds
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 118 (estimated)
- Sponsor
- Axio Biosolutions Pvt. Ltd. · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of MaxioCel vs Aquacel Extra in the management of exuding ulcers/wounds over a period of 4 weeks
Detailed description
The current study intends to compare the efficacy of the chitosan wound dressing (MaxioCel) with another marketed dressing (Aquacel Extra). MaxioCel is made up of chitosan and Aquacel Extra with carboxymethyl cellulose. Both are polymeric dressings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MaxioCel | Microfiber wound dressing |
| DEVICE | AquaCel Extra | Hydrofiber dressing |
Timeline
- Start date
- 2022-04-27
- Primary completion
- 2023-12-11
- Completion
- 2023-12-31
- First posted
- 2022-04-05
- Last updated
- 2023-10-26
Locations
5 sites across 1 country: India
Source: ClinicalTrials.gov record NCT05312762. Inclusion in this directory is not an endorsement.